Papillary thyroid microcarcinoma and active surveillance - Authors' reply

Affiliations

¹ Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, 94805 Villejuif, France. Electronic address: sophie.leboulleux@gustaveroussy.fr.
² Endocrinology Service, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA.
³ Section of Endocrinology, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
⁴ Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, 94805 Villejuif, France.

Comment

Sophie Leboulleux et al. Lancet Diabetes Endocrinol. 2016 Dec.

. 2016 Dec;4(12):976-977.

doi: 10.1016/S2213-8587(16)30326-6.

¹ Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, 94805 Villejuif, France. Electronic address: sophie.leboulleux@gustaveroussy.fr.
² Endocrinology Service, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA.
³ Section of Endocrinology, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
⁴ Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Université Paris Saclay, 94805 Villejuif, France.

No abstract available

Comment on

Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Leboulleux S, et al. Lancet Diabetes Endocrinol. 2016 Nov;4(11):933-942. doi: 10.1016/S2213-8587(16)30180-2. Epub 2016 Aug 20. Lancet Diabetes Endocrinol. 2016. PMID: 27550849 Review.
Papillary thyroid microcarcinoma and active surveillance.
Liu Z, Huang T. Liu Z, et al. Lancet Diabetes Endocrinol. 2016 Dec;4(12):974-975. doi: 10.1016/S2213-8587(16)30269-8. Lancet Diabetes Endocrinol. 2016. PMID: 27886749 No abstract available.
Papillary thyroid microcarcinoma and active surveillance.
Tulchinsky M. Tulchinsky M. Lancet Diabetes Endocrinol. 2016 Dec;4(12):974. doi: 10.1016/S2213-8587(16)30282-0. Lancet Diabetes Endocrinol. 2016. PMID: 27886750 No abstract available.
Papillary thyroid microcarcinoma and active surveillance.
Angelos P. Angelos P. Lancet Diabetes Endocrinol. 2016 Dec;4(12):975-976. doi: 10.1016/S2213-8587(16)30325-4. Lancet Diabetes Endocrinol. 2016. PMID: 27886751 No abstract available.
Papillary thyroid microcarcinoma and active surveillance.
Viola D. Viola D. Lancet Diabetes Endocrinol. 2016 Dec;4(12):975. doi: 10.1016/S2213-8587(16)30330-8. Lancet Diabetes Endocrinol. 2016. PMID: 27886752 No abstract available.